These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 30826174)

  • 1. Meningococcal C vaccine coverage in France in infants, children, and adolescents.
    Gaudelus J; Cohen R; Leboucher B; Stahl JP; Denis F; Pujol P; Longfier L; Martinot A
    Med Mal Infect; 2019 May; 49(3):180-186. PubMed ID: 30826174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution between 2008 and 2018 of mothers' perception regarding vaccination and infant vaccine coverage in France.
    Martinot A; Leboucher B; Cohen R; Stahl JP; Subtil D; Pujol P; Lepetit H; Longfier L; Gaudelus J
    Infect Dis Now; 2021 Mar; 51(2):153-158. PubMed ID: 33059002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination against meningococcus C. vaccinal coverage in the French target population.
    Stahl JP; Cohen R; Denis F; Gaudelus J; Lery T; Lepetit H; Martinot A
    Med Mal Infect; 2013 Feb; 43(2):75-80. PubMed ID: 23428390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Community outbreak of serogroup B invasive meningococcal disease in Beaujolais, France, February to June 2016: from alert to targeted vaccination.
    Thabuis A; Tararbit K; Taha MK; Dejour-Salamanca D; Ronin V; Parent du Chatelet I; Spaccaferri G
    Euro Surveill; 2018 Jul; 23(28):. PubMed ID: 30017022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of mandatory vaccination extension on infant vaccine coverages: Promising preliminary results.
    Cohen R; Gaudelus J; Leboucher B; Stahl JP; Denis F; Subtil D; Pujol P; Lepetit H; Longfier L; Martinot A
    Med Mal Infect; 2019 Feb; 49(1):34-37. PubMed ID: 30409542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential Coverage of the 4CMenB Vaccine against Invasive Serogroup B
    Mulhall RM; Bennett D; Cunney R; Borrow R; Lucidarme J; Findlow J; Jolley KA; Bray J; Maiden MCJ; Moschioni M; Serino L; Stella M; Medini D
    mSphere; 2018 Aug; 3(4):. PubMed ID: 30135218
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of meningococcal C conjugate vaccination programs with and without catch-up campaigns in adolescents: Lessons learned from Bahia, Brazil.
    Evellyn do Macedo L; Ferreira VM; Feitosa CA; Nunes AMPB; Campos LC; Sáfadi MAP
    Hum Vaccin Immunother; 2018 May; 14(5):1131-1137. PubMed ID: 29236585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine-preventable severe morbidity and mortality caused by meningococcus and pneumococcus: A population-based study in France.
    Lorton F; Chalumeau M; Assathiany R; Martinot A; Bucchia M; Roué JM; Bourgoin P; Chantreuil J; Boussicault G; Gaillot T; Saulnier JP; Caillon J; Levy C; Cohen R; Gras-Le Guen C; Launay E
    Paediatr Perinat Epidemiol; 2018 Sep; 32(5):442-447. PubMed ID: 30170336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meningococcal disease epidemiology in Brazil (2005-2018) and impact of MenC vaccination.
    Aparecido Nunes A; De Jesus Lopes De Abreu A; Cintra O; A C T Cintra M; Barbosa Coelho E; Nogueira Castro De Barros E
    Vaccine; 2021 Jan; 39(3):605-616. PubMed ID: 33358262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inequalities in the risk and prevention of invasive meningococcal disease in the United States - A systematic literature review.
    Begum S; Herrera-Restrepo O; Rolland C; Purushotham S; Andani A; Shah H; Kocaata Z
    Hum Vaccin Immunother; 2024 Dec; 20(1):2406613. PubMed ID: 39373020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasive meningococcal disease epidemiology and control measures: a framework for evaluation.
    Caro JJ; Möller J; Getsios D; Coudeville L; El-Hadi W; Chevat C; Nguyen VH; Caro I
    BMC Public Health; 2007 Jun; 7():130. PubMed ID: 17603880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact on disease incidence of a routine universal and catch-up vaccination strategy against Neisseria meningitidis C in Tuscany, Italy.
    Bechini A; Levi M; Boccalini S; Tiscione E; Balocchini E; Canessa C; Azzari C; Bonanni P
    Vaccine; 2012 Oct; 30(45):6396-401. PubMed ID: 22921931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surveillance for meningococcal disease and strategies for use of conjugate meningococcal vaccines in the United States.
    Lingappa JR; Rosenstein N; Zell ER; Shutt KA; Schuchat A; Perkins BA;
    Vaccine; 2001 Aug; 19(31):4566-75. PubMed ID: 11483285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiological impact and cost-effectiveness of introducing vaccination against serogroup B meningococcal disease in France.
    Lecocq H; Parent du Châtelet I; Taha MK; Lévy-Bruhl D; Dervaux B
    Vaccine; 2016 Apr; 34(19):2240-50. PubMed ID: 27002504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics and changes in invasive meningococcal disease epidemiology in France, 2006-2015.
    Parent du Chatelet I; Deghmane AE; Antona D; Hong E; Fonteneau L; Taha MK; Lévy-Bruhl D
    J Infect; 2017 Jun; 74(6):564-574. PubMed ID: 28279715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination of teenagers in France over a 10-year period (2012-2021).
    Gaudelus J; Cohen R; Stahl JP; Denigot M; Gelin P; Gruber A; Mediouni L; Martinot A
    Infect Dis Now; 2024 Sep; 54(6):104952. PubMed ID: 38950884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of invasive diseases: strategies to increase vaccination coverage in children and adolescents.
    Zoppi G; Trucchi C
    J Prev Med Hyg; 2012 Jun; 53(2):125-9. PubMed ID: 23240175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A decade of herd protection after introduction of meningococcal serogroup C conjugate vaccination.
    Bijlsma MW; Brouwer MC; Spanjaard L; van de Beek D; van der Ende A
    Clin Infect Dis; 2014 Nov; 59(9):1216-21. PubMed ID: 25069869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of hepatitis B vaccine coverage rates in France between 2008 and 2011.
    Denis F; Cohen R; Martinot A; Stahl JP; Lery T; Le Danvic M; Gaudelus J
    Med Mal Infect; 2013 Jul; 43(7):272-8. PubMed ID: 23876204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of meningococcal C conjugate vaccine in Salvador, Brazil: a case-control study.
    Cardoso CW; Ribeiro GS; Reis MG; Flannery B; Reis JN
    PLoS One; 2015; 10(4):e0123734. PubMed ID: 25874777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.